… and adult patients with status asthmaticus found insufficient evidence to … as an adjunct for
the treatment of status asthmaticus are weak, and methylxanthines are the only adjunct therapy …

… adjuncts to therapy of the stable asthmatic, are not helpful in the management of status
asthmaticus. … been efficacious in the treatment of adults with acute antigen-induced asthma.11, 65 …

… status asthmaticus, however, the use of second- and third-line medical therapies as well as
adjunctive therapies … , in patients failing medical and adjunctive therapy for SA, if available, …

… Although a definitive recommendation regarding IV magnesium as adjunct therapy in SA
patients cannot be supported at this time, there may be a subset of severe patients who benefit …

… Intravenously administered magnesium sulfate has been reported to be a useful adjunctive
therapy in patients with acute asthma refractory to treatment with inhaled betaagonists (136-…

… is essential for appropriate therapy and response to changes in patient status. The severe
asthmatic truly requires team effort for … It is often an effective adjunct to beta-agonist therapy. …

… for use in the treatment of status asthmaticus. Medical therapies can be broadly categorized
… Second-line therapies available as adjunctive bronchodilators for patients failing to improve …

… Patients with status asthmaticus who do not respond to standard therapy … Treatment options
for refractory status asthmaticus remain limited and alternative and controversial therapies …

… treatment fails and signs and symptoms of deteriorating airflow and respiratory muscle fatigue
are developing. These adjunctive therapies … in critically ill children with status asthmaticus. …

… As iv magnesium is safe and inexpensive, it is reasonable to use it as an adjunct to other
standard therapies, especially in the ICU, as patients with severe obstruction stand to benefit …